Personal Capital Advisors Increased Johnson & Johnson (JNJ) Holding By $3.72 Million; Shorts at Rice Midstream Partners Lpunits Representi (RMP) Lowered By 2.25%

August 12, 2018 - By Kristin Houston

Johnson & Johnson (NYSE:JNJ) Logo

Personal Capital Advisors Corp increased Johnson & Johnson (JNJ) stake by 15.08% reported in 2018Q1 SEC filing. Personal Capital Advisors Corp acquired 29,043 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Personal Capital Advisors Corp holds 221,698 shares with $28.41 million value, up from 192,655 last quarter. Johnson & Johnson now has $350.77B valuation. The stock decreased 0.34% or $0.45 during the last trading session, reaching $130.75. About 4.32 million shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since August 12, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 17/04/2018 – J&J QTRLY WORLDWIDE INVOKANA/INVOKAMET SALES $248 MLN VS $284 MLN REPORTED LAST YR; 30/03/2018 – ChicagoBreaking: Emanuel says Johnson decision on Rialmo is `not the end of the process’; 16/03/2018 – Johnson & Johnson: LifeScan Had 2017 Net Revenue of About $1.5B; 10/04/2018 – U.S. FDA SAYS GRANTED CLEARANCE OF THE ACUVUE OASYS CONTACT LENSES WITH TRANSITIONS LIGHT INTELLIGENT TECHNOLOGY TO JOHNSON & JOHNSON VISION CARE INC; 20/03/2018 – Johnson & Johnson to Host Investor Conference Call on First-Quarter Results; 16/05/2018 – #ASCO18 $JNJ FGFRi erdafitinib very nice data in FGFRalt bladder cancer -; 17/04/2018 – JNJ SAYS ACTELION IS DELIVERING AS EXPECTED; 12/04/2018 – Socrates Health Solutions, Developer of Socrates Companion™ Noninvasive Blood Glucose Self-Monitoring Device, Announces Expanded Role of John Maynard; 04/04/2018 – J&J Jury Set to Weigh Banker’s Claims Baby Powder Caused Cancer; 16/04/2018 – BRISTOL-MYERS SQUIBB ANNOUNCES WORLDWIDE COLLABORATION WITH JANSSEN TO DEVELOP & COMMERCIALIZE BRISTOL-MYERS’ FACTOR XIA INHIBITOR, BMS-986177

Rice Midstream Partners Lpunits Representi (NYSE:RMP) had a decrease of 2.25% in short interest. RMP’s SI was 2.72 million shares in August as released by FINRA. Its down 2.25% from 2.78 million shares previously. With 613,500 avg volume, 4 days are for Rice Midstream Partners Lpunits Representi (NYSE:RMP)’s short sellers to cover RMP’s short positions. The SI to Rice Midstream Partners Lpunits Representi’s float is 4.18%. The stock decreased 1.30% or $0.24 during the last trading session, reaching $18.16. About 438,856 shares traded or 197.69% up from the average. Rice Midstream Partners LP (NYSE:RMP) has declined 26.32% since August 12, 2017 and is downtrending. It has underperformed by 38.89% the S&P500. Some Historical RMP News: 26/04/2018 – RICE MIDSTREAM PARTNERS LP – EACH HOLDER OF COMMON UNIT OF RMP WILL RECEIVE 0.3319 UNITS OF EQM, REPRESENTING EQUITY VALUE OF $2.1 BLN; 03/05/2018 – Investor Expectations to Drive Momentum within Balchem, Beacon Roofing Supply, Rice Midstream Partners LP, LTC Properties, Ubiq; 26/04/2018 – RICE MIDSTREAM PARTNERS – EQM EXPECTS TO ALSO BORROW UNDER TERM LOAN FACILITY TO FINANCE 2018 EXPANSION CAPEX, MVP CAPITAL CONTRIBUTIONS; 26/04/2018 – RICE MIDSTREAM PARTNERS LP – EQM WILL ALSO ASSUME RMP DEBT, WHICH TOTALED $325 MLN AS OF MARCH 31, 2018; 26/04/2018 – RICE MIDSTREAM – BOARDS OF EQT AND EACH OF EQGP, EQM AND RMP, AS WELL AS CONFLICTS COMMITTEES OF EQGP, EQM AND RMP, UNANIMOUSLY APPROVED DEALS; 26/04/2018 – EQT Midstream Partners-Rice Midstream Partners Agreement Contains Termination Rights — Filin; 01/05/2018 – WeissLaw LLP: Rice Midstream Partners LP is the Subject of a Legal Investigation; 26/04/2018 – RICE MIDSTREAM PARTNERS LP – EQM HAS ENTERED INTO A $2.5 BLN 364-DAY SYNDICATED TERM LOAN FACILITY; 26/04/2018 – RICE MIDSTREAM PARTNERS LP – EQM SEES NET INCOME FOR 2018 OF $0.70 BLN – $0.80 BLN, FOR 2019 $0.95 BLN – $1.05 BLN; 15/03/2018 – EQT CORP – REAFFIRMS FISCAL YEAR 2018 GUIDANCE ANNOUNCED ON FEBRUARY 15, 2018

Investors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Sentinel Co Lba invested 0.21% in Johnson & Johnson (NYSE:JNJ). Mar Vista Prtnrs Ltd Liability Corporation has 387,912 shares. Seaward Mgmt Partnership accumulated 1.73% or 270,934 shares. Comerica Bancshares holds 0.9% or 983,044 shares. Bell Commercial Bank holds 0.13% or 3,164 shares in its portfolio. Daniel Devine And, Florida-based fund reported 30,457 shares. Gradient Invests Ltd Company holds 0.47% or 67,110 shares in its portfolio. 107,118 are held by First Bankshares Of Omaha. Tuttle Tactical stated it has 1.41% of its portfolio in Johnson & Johnson (NYSE:JNJ). Point72 Asset LP owns 0.21% invested in Johnson & Johnson (NYSE:JNJ) for 388,716 shares. Boyd Watterson Asset Management Limited Liability Com Oh reported 17,137 shares or 1.09% of all its holdings. Headinvest Ltd Limited Liability Company reported 0.73% of its portfolio in Johnson & Johnson (NYSE:JNJ). Tiverton Asset Mgmt Lc has invested 1.01% in Johnson & Johnson (NYSE:JNJ). Davenport & Limited Liability invested in 0% or 1.40 million shares. Focused Ltd holds 6.37% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 1.14 million shares.

Among 10 analysts covering Johnson \u0026 Johnson (NYSE:JNJ), 5 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. Johnson \u0026 Johnson had 15 analyst reports since February 27, 2018 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Friday, March 23. On Friday, April 20 the stock rating was maintained by Credit Suisse with “Outperform”. The rating was maintained by Deutsche Bank on Wednesday, April 18 with “Buy”. The firm has “Buy” rating given on Thursday, May 17 by Leerink Swann. Credit Suisse maintained the shares of JNJ in report on Tuesday, June 12 with “Buy” rating. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Friday, April 13 by Jefferies. The stock has “Hold” rating by Stifel Nicolaus on Wednesday, April 18. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Monday, February 26 by Jefferies. Citigroup maintained the shares of JNJ in report on Tuesday, February 27 with “Neutral” rating. The firm has “Buy” rating by Wells Fargo given on Wednesday, April 18.

Since February 15, 2018, it had 0 insider buys, and 1 sale for $20.17 million activity. 155,342 shares were sold by Stoffels Paulus, worth $20.17M on Thursday, February 15.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson Looks Too Cheap” on July 17, 2018, also Benzinga.com with their article: “Earnings Preview: Healthcare Giant Johnson & Johnson Set To Report Tuesday Morning” published on July 16, 2018, Seekingalpha.com published: “J&J: Lawsuits And Dividend Safety” on July 27, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fool.com and their article: “Better Buy: Johnson & Johnson vs. Pfizer” published on August 02, 2018 as well as Seekingalpha.com‘s news article titled: “Johnson & Johnson: Headline Risk But Business Solid” with publication date: August 07, 2018.

Personal Capital Advisors Corp decreased Vanguard Index Fds (VUG) stake by 2,160 shares to 4,111 valued at $583,000 in 2018Q1. It also reduced Stepan Co (NYSE:SCL) stake by 9,275 shares and now owns 101,208 shares. Schwab Strategic Tr (SCHB) was reduced too.

Rice Midstream Partners LP owns, operates, develops, and acquires midstream assets in the Appalachian Basin. The company has market cap of $1.86 billion. It operates in two divisions, Gathering and Compression; and Water Services. It has a 10.15 P/E ratio. The Company’s natural gas gathering and compression assets consist of natural gas gathering and compression systems that service producers in the dry gas core of the Marcellus Shale in southwestern Pennsylvania.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts